Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02764853 · ClinicalTrials.gov registry record · NA
Striving Towards EmPowerment and Medication Adherence (STEP-AD)
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
NCT02764853: Completed NA study, sponsored by University of Miami.
NCT02764853 is a NA study that has completed, run by University of Miami. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02764853, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
Study Summary
Striving Towards Empowerment and Medication Adherence (STEP-AD) is a research study aimed at developing an intervention for Black women living with HIV to address psychosocial factors (i.e. abuse/trauma histories, racial discrimination, HIV stigma/discrimination, and prescribed traditional gender roles) that have been associated with medication nonadherence or poor HIV outcomes (e.g. viral load, CD4), but are unaddressed in existing interventions.
Primary Outcome
Adherence to antiretroviral therapy (ART) as captured by the Wisepill electronic adherence monitor. Change from baseline adherence.
Interventions
- BEHAVIORAL Enhanced Treatment as Usual (E-TAU)
- BEHAVIORAL Experimental Intervention (STEP-AD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
What the finished NCT02764853 record still lists
NCT02764853 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced Treatment as Usual (E-TAU) is the first listed.
NCT02764853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02764853 about?
NCT02764853 is a clinical study titled "Striving Towards EmPowerment and Medication Adherence (STEP-AD)". Striving Towards Empowerment and Medication Adherence (STEP-AD) is a research study aimed at developing an intervention for Black women living with HIV to address psychosocial factors (i.e. abuse/trauma histories, racial discrimination, HIV stigma/discrimination, and prescribed traditional gender ro...
What is the current status of trial NCT02764853?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2015-12. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT02764853?
The interventions under investigation include: Enhanced Treatment as Usual (E-TAU) (BEHAVIORAL), Experimental Intervention (STEP-AD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02764853?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02764853's enrollment target sits among peer trials
184 581st of 2000 higher than 1,417 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia